ISSN: 1745-7580
+44-77-2385-9429
Mustafa Elhag, Ruaa Mohamed Alaagib, Esraa Musa Haroun, Nagla Mohamed Ahmed, Sahar Obi Abd Albagi, Mohammed A.Hassan
Schistosoma Mansoni represents an important tropical disease that can cause schistosomiasis mostly in Africa and Middle East with high mortality rates. Moreover, no vaccine against it exists. This study predicts an effective epitope-based vaccine against Fructose 1,6 Bisphosphate Aldolase (FBA) enzyme of Schistosoma Mansoni using immunoinformatics approaches. FBA is important for production of energy required for different schistosome activities and survival. The sequences were retrieved from NCBI and several prediction tests were conducted to analyze possible epitopes for B-cell, T-cell MHC Class I and II. Tertiary structure of the most promising epitopes was obtained. Two epitopes showed high binding affinity for B-cells, while four epitopes showed high binding affinity for MHCI and MHCII. The results were promising to formulate a vaccine with more than 99.5% population coverage. We hope that these promising epitopes serves as a preventive measure for the disease in the future and recommend in vivo and in vitro studies
Published Date: 2021-02-19; Received Date: 2021-01-28